The amount of additional milestones payable under the arrangement.

No definition available.

The amount of annual maintenance fee payable under the arrangement.

No definition available.

The amount of contribution to be paid toward patient costs.

No definition available.

The amount of milestones payable under the arrangement.

No definition available.

Represents total payments for reimbursable expenses over the lifetime of the agreement.

No definition available.

The amount of contribution to be paid per patient under the arrangement.

No definition available.

The term of the research arrangement.

No definition available.

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373